Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 70

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 4
Chunk 70
---
 held by others.

In the regular course of business, our patents may be challenged by third parties. We are party to litigation or other proceedings relating to intellectual property rights. Details of material ongoing litigation are provided in Note 32 to our audited consolidated financial statements included in this annual report.

The following table describes our outstanding substance patents and the regulatory protection (“ RP”) (U. S. and EU) or re-examination period (“ RP”) (Japan) for the indicated product by territory and expiry date. Patent term extensions (“ PTE”), SPC and pediatric exclusivity periods (“ PEP”) are reflected in the expiry dates to the extent they have been granted by the issuing authority. For PTE’s, SPC’s and PEP’s in which the application is in process but not yet granted, the extended expiry is separately provided.

Our biologic products may face or already face competition from companies who produce similar products for the same indications, and/or biosimilars, regardless of expiry dates below. Certain European patents may be the subject of supplemental protection certificates that provide additional protection for the product in certain countries beyond the dates listed in the table.

  Our product                 Japan expiry dates (1)(2)      U. S. expiry dates (1)      EU expiry dates (1)  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Gastroenterology (GI):                                                                                      
  ENTYVIO                     Patent: -                      Patent: -                   Patent: -            
  GATTEX/REVESTIVE            Patent: -                      Patent: - (5)               Patent: -            
  TAKECAB (3)                 Patent: August 2031            Patent: - (3)               Patent: - (3)        
  PANTOLOC /CONTROLOC         Not commercialized             Patent: -                   Patent: -            
  DEXILANT                    Not commercialized             Patent: -                   Patent: -            
  LIALDA/MEZAVANT (3)         Patent: - (3)                  Patent: -                   Patent: -            
  RESOLOR/MOTEGRITY           Not commercialized             Patent: -                   Patent: -            
  EOHILIA                     Not commercialized             Patent: -                   Not commercialized   

Table of Contents

  Our product            Japan expiry dates (1)(2)                           U. S. expiry dates (1)      EU expiry dates (1)    
 ─────────────────────────────────────────────────────────────────────────